Kenya to launch Ksh4.7 billion Ebola vaccine trial in 2027 as DRC expands Tumaini study

In brief

Scientists have added two vaccines built specifically against Bundibugyo Ebola virus to a trial in the DRC, while Kenya to launch Ksh4.7 billion Ebola vaccine trial in 2027 as DRC expands Tumaini study. Reported by K24 Digital on 14-11-2026. The full report is available from the publisher.